Laurion Capital Management LP Bristol Myers Squibb CO Transaction History

Laurion Capital Management LP

$8.4 Billion
Q2 2024

A detailed history of Laurion Capital Management LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Laurion Capital Management LP holds 9,507 shares of BMY stock, worth $484,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,507

Previous 1,675,583 99.43%

Holding current value

$484,096

Previous $90.9 Million 99.57%

% of portfolio

0.0%

Previous 0.79%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $67.1 Million - $88.3 Million	-1,666,076 Reduced 99.43%	9,507 $394,000
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $11.9 Million - $13.5 Million	248,986 Added 17.45%	1,675,583 $90.9 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $28.3 Million - $33.7 Million	583,268 Added 69.16%	1,426,597 $73.2 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $53.7 Million - $59.7 Million	843,329 New	843,329 $53.9 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $74 - $43,798	570 New	570 $41,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $9.2 Million - $10.7 Million	-171,600 Reduced 90.54%	17,935 $1.12 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $10.8 Million - $12.7 Million	182,945 Added 2776.1%	189,535 $11.2 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $407,986 - $444,297	6,590 New	6,590 $440,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $51.8 Million - $58.2 Million	-872,140 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $18.3 Million - $20.7 Million	316,954 Added 57.09%	872,140 $54.1 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $8.56 Million - $9.48 Million	149,004 Added 36.68%	555,186 $33.5 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $151 Million - $176 Million	-2,746,144 Reduced 87.11%	406,182 $23.9 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $132 Million - $193 Million	2,854,960 Added 960.08%	3,152,326 $176 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $11.8 Million - $13.1 Million	265,233 Added 825.42%	297,366 $13.5 Million
Q1 2019 May 08, 2019	BUY	$45.12 - $53.8 $449,034 - $535,417	9,952 Added 44.87%	32,133 $1.53 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $1.04 Million - $1.36 Million	21,430 Added 2853.53%	22,181 $1.15 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $1.24 Million - $1.4 Million	-22,516 Reduced 96.77%	751 $47,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $10.8 Million - $13.5 Million	-214,481 Reduced 90.21%	23,267 $1.29 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $13.7 Million - $14.9 Million	227,748 Added 2277.48%	237,748 $14.6 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $552,300 - $637,400	10,000	10,000 $637,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Account

Laurion Capital Management LP Bristol Myers Squibb CO Transaction History